Postpolypectomy coagulation syndrome

Postpolypectomy coagulation syndrome, also called postpolypectomy syndrome or transmural burn syndrome, is a self-limiting thermal injury of the colonic wall caused by electrocautery during colonoscopic polypectomy that reaches the serosa and produces a localised peritonitis without free perforation.

It is one of the three classic adverse events of polypectomy alongside bleeding and perforation, is reported after roughly 0.14 to 2 per cent of procedures, and matters clinically because it mimics perforation and appendicitis and can lead to unnecessary laparotomy when it is not recognised.

Terminology and classification

• The standard English name is postpolypectomy coagulation syndrome, abbreviated PPCS, and the alternative post-polypectomy electrocoagulation syndrome, abbreviated PPECS, is used when authors wish to emphasise the electrical mechanism.
• Older reports called the same clinical picture transmural burn syndrome or postpolypectomy syndrome, and the three labels still appear interchangeably in endoscopy reporting systems and in consent documents.
• ICD-10 has no dedicated code and the event is captured only by the residual category T81.8 for other complications of procedures not elsewhere classified, so the code should never be presented as a specific diagnosis.
• ICD-11 release 2025-01 behaves in the same way and offers only the non-specific postprocedural category NE81.Z, which is why the syndrome is usually classified in the literature by its mechanism rather than by a code.
• Interoperability anchors are sparse because the entity is an iatrogenic complication rather than a disease: Wikidata Q104879176 and UMLS CL976409 are the main concept identifiers, and no MONDO or Orphanet class was identified for it.
• The 2010 ASGE lexicon of endoscopic adverse events, published by Cotton and colleagues, recognised postpolypectomy syndrome as a distinct postprocedural event and separated it from intraprocedural bleeding, delayed bleeding and perforation.

History

• Colonoscopic snare polypectomy was developed in the early 1970s by Hiromi Shinya and William Wolff, and the technique spread rapidly because it removed adenomas without laparotomy.
• The first descriptions of a transmural thermal burn after polypectomy appeared in the late 1970s and early 1980s, when endoscopists reported localised peritonitis in patients whose laparotomy found no perforation.
• Computed tomography in the 1980s and 1990s provided the decisive test, because it showed colonic wall thickening and pericolic fat stranding without free gas and allowed clinicians to avoid surgery.
• Recognition that the lesion heals spontaneously converted management from early laparotomy to observation, intravenous fluids and antibiotics, a shift documented in the case series of the 1990s.
• The ASGE lexicon of 2010 standardised the definition and made the syndrome a reportable adverse event, which improved comparison of complication rates between endoscopy units.
• Cold snare polypectomy, reintroduced and scaled up after 2010, and the 2020 European Society of Gastrointestinal Endoscopy polypectomy guideline together shifted the risk profile by reserving thermal current for larger or fibrous lesions.

Epidemiology

• Reported incidence ranges from 0.14 to 2 per cent of colonoscopic polypectomies in modern series, and the wide range reflects differences in lesion size, electrocautery settings and the threshold for imaging.
• For large non-pedunculated lesions removed by piecemeal hot snare resection the incidence rises to 1.35 to 3.7 per cent, which makes lesion size the strongest single predictor.
• Hospital admission is required in about 0.07 per cent of all polypectomies, and most other episodes are managed at home or with a short emergency department stay, so clinic-based series overstate severity.
• Reported associations include right-sided colonic location, lesion diameter above 2 centimetres, laterally spreading or non-polypoid morphology, prolonged current application and a history of hypertension.
• Symptoms usually begin 12 hours to 5 days after the procedure, with most cases presenting within 24 to 48 hours, which is the window in which a recent polypectomy should be sought in the history.
• No consistent sex predilection has been demonstrated, and the age distribution simply follows the age distribution of adenomas, so most patients are in the sixth to eighth decades.
• Cold snare resection of small polyps is associated with almost no thermal injury, and units that adopted it as the default for lesions under 10 millimetres report a fall in the syndrome.
• Named surveillance sources include the English Bowel Cancer Screening Programme, which audits post-colonoscopy complications for every screened patient, and the US GI Quality Improvement Consortium registry, which reports adverse events per 1,000 colonoscopies.

Pathophysiology

• Monopolar electrocautery delivers alternating current through the polyp and the colonic wall, and tissue resistance converts electrical energy into heat that coagulates protein and seals vessels.
• Coagulation current produces a slower, deeper and wider zone of heating than pure cutting current, and depth increases with power setting, application time and the area of electrode contact.
• In the thin-walled right colon and at the base of a large sessile lesion, heat can reach the muscularis propria and serosa, producing serositis and a localised fibrinous peritonitis.
• Because the wall remains intact there is no free intraperitoneal gas, but transmural inflammation permits bacterial translocation and explains the fever and leukocytosis that accompany the pain.
• Histology shows coagulation necrosis of the mucosa and submucosa, oedema of the muscularis, neutrophilic infiltration and later granulation tissue, and healing leaves a shallow scar rather than a defect.
• Submucosal injection of saline, succinylated gelatin or hyaluronic acid lifts the lesion away from the muscularis and increases the thickness of the heat sink between the snare and the serosa.

Clinical features

• The cardinal presentation is abdominal pain that begins hours to days after an otherwise uncomplicated polypectomy, is usually localised to the segment that was treated and is worsened by movement or coughing.
• Peritoneal signs such as guarding, rebound tenderness and absent bowel sounds are common, and their presence is what makes the condition clinically indistinguishable from perforation at the bedside.
• Fever of 38 to 39 degrees Celsius, rigors, nausea, vomiting and a low-grade ileus are typical, and the combination of pain and fever after polypectomy is the classic trigger for imaging.
• Leukocytosis of 12,000 to 20,000 cells per microlitre and a raised C-reactive protein are expected, while overt sepsis with hypotension or organ dysfunction is uncommon.
• Mild episodes settle over two to five days with bowel rest, whereas pain that persists beyond a week, worsening peritonism or haemodynamic instability suggests an alternative diagnosis or a complication.
• Named complications are progression to perforation, pericolic or pelvic abscess, sepsis, prolonged ileus and unnecessary laparotomy performed for a presumed perforation.

Diagnosis

• Diagnosis is clinical and rests on the triad of a recent polypectomy within five days, localised abdominal pain with peritoneal signs, and the absence of free intraperitoneal gas on imaging.
• Contrast-enhanced computed tomography of the abdomen and pelvis is the key test and shows focal wall thickening, pericolic fat stranding and fluid, with no free gas and no visible mural defect.
• Plain radiography is normal in most cases and can neither confirm the syndrome nor exclude a sealed perforation, so a normal abdominal film should not stop computed tomography when peritoneal signs are present.
• Laboratory testing supports the diagnosis rather than establishing it: full blood count, C-reactive protein, lactate and blood cultures are obtained, and a lactate above 2 millimoles per litre warrants reassessment for sepsis.
• The differential diagnosis includes perforation, which shows free gas or a visible defect, postpolypectomy bleeding, appendicitis, diverticulitis, ischaemic colitis and acute cholecystitis.
• Repeat colonoscopy is not indicated and may worsen the injury, and a water-soluble contrast enema is reserved for the rare patient in whom a sealed perforation must be excluded before starting anticoagulation.
• Documentation should follow the 2010 ASGE lexicon and record the event type, severity grade, timing relative to the procedure and the treatment given, because this classification drives unit-level quality reporting.

Management

• Management is conservative in almost every case, with the aims of bowel rest, analgesia, correction of dehydration and prevention of progression to abscess or sepsis.
• Patients are admitted for observation, kept nil by mouth initially, given intravenous crystalloid and reassessed with serial abdominal examinations every 6 to 12 hours.
• Broad-spectrum antibiotics covering enteric Gram-negative organisms and anaerobes are used when fever, leukocytosis or peritoneal signs are present, typically ceftriaxone plus metronidazole or piperacillin-tazobactam.
• Analgesia is given with paracetamol and, when needed, short courses of opioids, although opioids can mask worsening peritonism and therefore require careful review.
• Surgery is reserved for perforation, abscess, persistent sepsis or diagnostic uncertainty, and operative findings in true coagulation syndrome are serosal inflammation without a wall defect.
• Prognosis is excellent, with resolution within two to five days in the great majority, no long-term stricture and no measurable loss of colonic function.
• Prevention rests on technique: cold snare resection for lesions under 10 millimetres as recommended by the 2020 ESGE guideline, submucosal injection for large lesions, minimising current duration and avoiding coagulation of the residual stalk.
• After recovery, surveillance intervals follow the 2020 British Society of Gastroenterology post-polypectomy guideline, which stratifies by polyp number, size and histology rather than by the occurrence of this complication.

Research and controversies

• True incidence remains unknown because mild episodes managed at home never enter endoscopy databases, and the 0.14 to 2 per cent range partly reflects this reporting bias.
• Randomised trials of cold snare versus hot snare resection for small polyps have shown fewer thermal adverse events with the cold technique, although the trials were powered for bleeding rather than for coagulation syndrome.
• Prophylactic clip closure of large endoscopic mucosal resection defects has been tested in randomised trials with inconsistent effects on delayed bleeding, and its effect on serositis has not been measured.
• No randomised trial has compared antibiotic strategies, and whether antibiotics are needed at all in afebrile patients with mild pain is an explicit open question in reviews of post-polypectomy adverse events.
• Research priorities include imaging criteria that predict progression, biomarkers such as procalcitonin to separate serositis from sepsis, and prospective registries linking electrocautery settings to outcome.